Sarcopenia, Aging and Prospective Interventional Strategies

Research output: Contribution to journal › Review › Research › peer-review

Standard

Sarcopenia, Aging and Prospective Interventional Strategies. / Waltz, Tyler B; Fivenson, Elayne M; Morevati, Marya; Li, Chuanhao; Becker, Kevin G; Bohr, Vilhelm A; Fang, Evandro F.

In: Current Medicinal Chemistry, Vol. 25, No. 40, 2018, p. 5588-5596.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Waltz, TB, Fivenson, EM, Morevati, M, Li, C, Becker, KG, Bohr, VA & Fang, EF 2018, 'Sarcopenia, Aging and Prospective Interventional Strategies', Current Medicinal Chemistry, vol. 25, no. 40, pp. 5588-5596. https://doi.org/10.2174/0929867324666170801095850

APA

Waltz, T. B., Fivenson, E. M., Morevati, M., Li, C., Becker, K. G., Bohr, V. A., & Fang, E. F. (2018). Sarcopenia, Aging and Prospective Interventional Strategies. Current Medicinal Chemistry, 25(40), 5588-5596. https://doi.org/10.2174/0929867324666170801095850

Vancouver

Waltz TB, Fivenson EM, Morevati M, Li C, Becker KG, Bohr VA et al. Sarcopenia, Aging and Prospective Interventional Strategies. Current Medicinal Chemistry. 2018;25(40):5588-5596. https://doi.org/10.2174/0929867324666170801095850

Author

Waltz, Tyler B ; Fivenson, Elayne M ; Morevati, Marya ; Li, Chuanhao ; Becker, Kevin G ; Bohr, Vilhelm A ; Fang, Evandro F. / Sarcopenia, Aging and Prospective Interventional Strategies. In: Current Medicinal Chemistry. 2018 ; Vol. 25, No. 40. pp. 5588-5596.

Bibtex

@article{1e5e64f2204b411382efa25d18de3479,

title = "Sarcopenia, Aging and Prospective Interventional Strategies",

abstract = "Sarcopenia, or age-related muscle decline, occurs in most organisms and burdens both human health and the healthcare system. As our population ages, additional options for treating sarcopenia are needed. Mitochondrial dysfunction is implicated in the onset of sarcopenia, so therapies directed at improving mitochondrial function in muscle should be considered. Many naturally-occurring compounds, derived from commonly consumed foods, possess anti-sarcopenic effects, such asnicotinamide riboside, tomatidine, and Urolithin A. These naturally-occurring compounds can improve mitochondrial health and efficiency by modulating mitochondrial biogenesis, cellular stress resistance, or mitophagy. Further research should assess whether compounds that improve mitochondrial health can attenuate sarcopenia in humans.",

author = "Waltz, {Tyler B} and Fivenson, {Elayne M} and Marya Morevati and Chuanhao Li and Becker, {Kevin G} and Bohr, {Vilhelm A} and Fang, {Evandro F}",

note = "Copyright{\textcopyright} Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.",

year = "2018",

doi = "10.2174/0929867324666170801095850",

language = "English",

volume = "25",

pages = "5588--5596",

journal = "Current Medicinal Chemistry",

issn = "0929-8673",

publisher = "Bentham Science Publishers",

number = "40",

}

RIS

TY - JOUR

T1 - Sarcopenia, Aging and Prospective Interventional Strategies

AU - Waltz, Tyler B

AU - Fivenson, Elayne M

AU - Morevati, Marya

AU - Li, Chuanhao

AU - Becker, Kevin G

AU - Bohr, Vilhelm A

AU - Fang, Evandro F

PY - 2018

Y1 - 2018

N2 - Sarcopenia, or age-related muscle decline, occurs in most organisms and burdens both human health and the healthcare system. As our population ages, additional options for treating sarcopenia are needed. Mitochondrial dysfunction is implicated in the onset of sarcopenia, so therapies directed at improving mitochondrial function in muscle should be considered. Many naturally-occurring compounds, derived from commonly consumed foods, possess anti-sarcopenic effects, such asnicotinamide riboside, tomatidine, and Urolithin A. These naturally-occurring compounds can improve mitochondrial health and efficiency by modulating mitochondrial biogenesis, cellular stress resistance, or mitophagy. Further research should assess whether compounds that improve mitochondrial health can attenuate sarcopenia in humans.

AB - Sarcopenia, or age-related muscle decline, occurs in most organisms and burdens both human health and the healthcare system. As our population ages, additional options for treating sarcopenia are needed. Mitochondrial dysfunction is implicated in the onset of sarcopenia, so therapies directed at improving mitochondrial function in muscle should be considered. Many naturally-occurring compounds, derived from commonly consumed foods, possess anti-sarcopenic effects, such asnicotinamide riboside, tomatidine, and Urolithin A. These naturally-occurring compounds can improve mitochondrial health and efficiency by modulating mitochondrial biogenesis, cellular stress resistance, or mitophagy. Further research should assess whether compounds that improve mitochondrial health can attenuate sarcopenia in humans.

U2 - 10.2174/0929867324666170801095850

DO - 10.2174/0929867324666170801095850

M3 - Review

C2 - 28762310

VL - 25

SP - 5588

EP - 5596

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 40

ER -

ID: 213241620